Senior insider sale
Chief Executive Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$928.4K
280K shares
What this filing means
GIBSON CHRISTOPHER plans to sell 280K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $928.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/18/2026ACC: 0001959173-26-004757
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
280K
Shares to sell
$928.4K
Approx. market value
40K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
9/1/2016
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2016 | Founders Shares Compensation | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
40K
Market value
$144.8K
6/5/2026
—Completed
Units to sell
40K
Market value
$123.2K
5/22/2026
—Completed
Units to sell
40K
Market value
$134.8K
5/7/2026
—Completed
Units to sell
40K
Market value
$144.4K
4/22/2026
—Completed
Units to sell
40K
Market value
$124.0K
4/7/2026
—Completed
Units to sell
40K
Market value
$130.0K
3/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
40K
Market value
$127.2K
6/18/2026
Total
Units
280K
Value
$928.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/5/2026 | 40K | $144.8K | — | Completed |
5/22/2026 | 40K | $123.2K | — | Completed |
5/7/2026 | 40K | $134.8K | — | Completed |
4/22/2026 | 40K | $144.4K | — | Completed |
4/7/2026 | 40K | $124.0K | — | Completed |
3/23/2026 | 40K | $130.0K | — | Completed |
| Planned — Approximate Date | ||||
6/18/2026 | 40K | $127.2K | NASDAQ | Planned |
| Total | 280K | $928.4K | ||